Paid Clinical Trials in Glen Burnie, MD
As of June 2026, 69 paid clinical trials are recruiting in Glen Burnie, Maryland. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Glen Burnie offers studies at sites including UM Baltimore Washington Medical Center/Tate Cancer Center for conditions such as Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Colitis, Ulcerative, Crohn's Disease. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Glen Burnie
Trials by drug in Glen Burnie
Filter results
69 clinical trials
↓ Download CSVStudy of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer
GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries
A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin
UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Brief Motivational Interviewing +/- Mindfulness Training for Adolescent Alcohol Use in Pediatric Primary Care
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
E-Mindfulness Approaches for Living After Breast Cancer
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Continuation Protocol for Obstructive Sleep Apnea (OSA)
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Testing the Pain Clinical Practice Guideline
About research studies in Glen Burnie
Glen Burnie has approximately 69 recruiting research studies across a wide range of therapeutic areas. Maryland hosts Johns Hopkins Medicine and the NIH Clinical Center in Bethesda, giving participants access to some of the most advanced early-phase research in the country.
Top Research Study Locations in Glen Burnie
Researchers run research studies in Glen Burnie, MD at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UM Baltimore Washington Medical Center/Tate Cancer Center | Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma | 24 |
| United Theranostics | Breast Cancer, Breast Neoplasms, Cervical Adenocarcinoma | 7 |
| Baltimore Washington Medical Center | Brain Tumor, Glioblastoma, Glioma | 6 |
| University of Maryland Baltimore Washington Medical Center | Healthy Volunteers (HV), Unhealthy Volunteers, Breast Cancer (Locally Advanced or Metastatic) | 5 |
| Woodholme Gastroenterology Associates | Crohn's Disease, Colitis, Ulcerative, Crohn Disease | 5 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Baltimore Washington Medical Center- Tate Cancer Center | Cervical Cancer, Gynaecologic Cancer, Non-Small Cell Lung Cancer | 2 |
| Woodholme Gastroenterology | Chronic Idiopathic Constipation (CIC), Crohn's Disease, Ulcerative Colitis | 2 |
| Advanced Molecular Imaging and Therapy | Breast Cancer, Cervical Cancer, Colon Cancer | 1 |
| Akero Clinical Study Site | MASH With Fibrosis, NASH With Fibrosis | 1 |
| Clearway Pain Solutions | Lumbar Spinal Stenosis | 1 |
| Clinical Insights | Treatment Resistant Depression | 1 |
| Johns Hopkins Community Physicians, Glen Burnie | Adolescent Alcohol Use | 1 |
| National Spine and Pain Centers | Lumbar Spinal Stenosis | 1 |
| Research Facility | Carcinoid, Carcinoid Tumor, GEP-NET | 1 |
| Sleep Disorders Centers of the Mid-Atlantic | OSA | 1 |
| SurgCenter of Glen Burnie | Lumbar Spinal Stenosis | 1 |
| TG Therapeutics Investigational Trial Site | Multiple Sclerosis, Relapsing Multiple Sclerosis | 1 |
| Tate Cancer Center at UM Baltimore Washington | Breast Cancer | 1 |
| United Theranostics - Chesapeake | Breast Cancer, Cervical Cancer, Colon Cancer | 1 |
| University of Maryland - Baltimore Washington Medical Center | Respiratory Distress Syndrome, Acute | 1 |
| Woodholme Gastroenterology Associates - Glen Burnie | Overweight or Obesity and Elevated Liver Fat | 1 |
| Woodholme Gastroenterology Associates PA | Colitis, Ulcerative | 1 |
| communicare Marley Station | Dementia, Pain | 1 |
Active & Upcoming Studies in Glen Burnie (2026)
Recruiting trials in Glen Burnie grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (42 active studies)
- Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer · University of Maryland, Baltimore
- Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors · Phase 1, Phase 2 · Molecular Partners AG
Diabetes & metabolic (4 active studies)
Mental health & behavior (2 active studies)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
- A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression · LivaNova
Neurology & pain (2 active studies)
- A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS) · TG Therapeutics, Inc.
- Testing the Pain Clinical Practice Guideline · Phase 2 · University of Maryland, Baltimore
Pediatric (1 active study)
Common conditions studied in Glen Burnie
- Breast Cancer (8 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Colitis, Ulcerative (3 active studies). Recruiting Colitis, Ulcerative studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Crohn's Disease (3 active studies). Recruiting Crohn's Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Glioblastoma (3 active studies). Glioblastoma studies investigate tumor-treating fields, targeted small molecules, and immunotherapy combinations for this aggressive brain cancer.
- Prostate Adenocarcinoma (3 active studies). Recruiting Prostate Adenocarcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Glen Burnie
- University of Maryland, Baltimore
- NRG Oncology
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- ECOG-ACRIN Cancer Research Group
Local regulations and guidelines
Clinical trials in Maryland are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Maryland research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Glen Burnie. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Glen Burnie
Hipa.ai aggregates every recruiting study in Glen Burnie from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Glen Burnie?
There are approximately 69 recruiting clinical trials in Glen Burnie, Maryland listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Glen Burnie pay participants?
Most recruiting trials in Glen Burnie compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Glen Burnie?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Glen Burnie?
The most common conditions under active study in Glen Burnie include Breast Cancer (8), Anatomic Stage II Breast Cancer AJCC v8 (3), Colitis, Ulcerative (3), Crohn's Disease (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Glen Burnie?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Glen Burnie on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Glen Burnie?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Glen Burnie?
Recruiting research sites in Glen Burnie include UM Baltimore Washington Medical Center/Tate Cancer Center, United Theranostics, Baltimore Washington Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Glen Burnie right now?
The largest active categories in Glen Burnie are Cancer & tumors (42), Diabetes & metabolic (4), Mental health & behavior (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.